We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Opaganib significantly reduced mortality and improved ...

Proposed study intended to evaluate the safety and efficacy of opaganib in up to 60 patients hospitalized with positive SARS-CoV-2 infection and pneumonia in the U.S. Opaganib’s uniquemechanism of ...

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary ...

TEL AVIV, Israel and RALEIGH, N.C., Sept. 7, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced results of ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of ...

Strong preclinical data, published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo studies, supports opaganib’s potential as a nuclear radiation injury ...

Potential high value and de-risked development pathway: Existing human safety and tolerability data from over 470 subjects, from several clinical programs, may help expedite the FDA pathway to ...

[Asia Economy Reporter Jang Hyowon] RedHill Biopharma, a US-Israeli biotechnology company in which Kookbo, a KOSPI-listed company, has acquired shares, announced on the 12th that in an in vitro ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under ...

USPTO grants new method of use patent for the inhibition of a disease caused by a coronavirus in patients having pneumonia and receiving supplemental oxygen at a fraction of inspired oxygen (FiO2) up ...

(RTTNews) - Biopharmaceutical company RedHill Biopharma Ltd. (RDHL) on Monday provided an additional update on the compassionate use program with its investigational drug, opaganib (Yeliva, ...

RedHill Biopharma (RDHL) announced positive results from new in vivo studies of opaganib as a treatment for gastrointestinal acute radiation syndrome, or GI-ARS, undertaken as part of the U.S.